Cargando…
Asperlin Stimulates Energy Expenditure and Modulates Gut Microbiota in HFD-Fed Mice
Asperlin is a marine-derived, natural product with antifungal, anti-inflammatory and anti-atherosclerotic activities. In the present study, we showed that asperlin effectively prevented the development of obesity in high-fat diet (HFD)-fed mice. Oral administration of asperlin for 12 weeks significa...
Autores principales: | Wu, Chongming, Zhou, Yue, Qi, Guihong, Liu, Dong, Cao, Xiaoxue, Yu, Jiaqi, Zhang, Rong, Lin, Wenhan, Guo, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356881/ https://www.ncbi.nlm.nih.gov/pubmed/30634484 http://dx.doi.org/10.3390/md17010038 |
Ejemplares similares
-
Asperlin Inhibits LPS-Evoked Foam Cell Formation and Prevents Atherosclerosis in ApoE(−/−) Mice
por: Zhou, Yue, et al.
Publicado: (2017) -
Phytohemagglutinin ameliorates HFD-induced obesity by increasing energy expenditure
por: Zhang, Yunxia, et al.
Publicado: (2021) -
The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats
por: Gao, Yi, et al.
Publicado: (2021) -
Dihydroquercetin Supplementation Improved Hepatic Lipid Dysmetabolism Mediated by Gut Microbiota in High-Fat Diet (HFD)-Fed Mice
por: Wang, Mengyu, et al.
Publicado: (2022) -
Calebin-A prevents HFD-induced obesity in mice by promoting thermogenesis and modulating gut microbiota
por: Lee, Pei-Sheng, et al.
Publicado: (2022)